The scientist’s investigation covers issues in Cell biology, Biochemistry, Kinase, Proto-oncogene tyrosine-protein kinase Src and Phosphorylation. Kavita Shah works mostly in the field of Cell biology, limiting it down to concerns involving Tip link and, occasionally, Stimulus. Her Biochemistry study focuses mostly on Binding site and Cyclin-dependent kinase 1.
Her Cyclin-dependent kinase 1 research is multidisciplinary, incorporating elements of Structural biology, Cyclin-dependent kinase and Cell signaling. As part of her studies on Kinase, Kavita Shah frequently links adjacent subjects like Molecular biology. The concepts of her Proto-oncogene tyrosine-protein kinase Src study are interwoven with issues in Tyrosine kinase, Cyclin-dependent kinase 9 and Tyrosine phosphorylation.
Cell biology, Biochemistry, Kinase, Cancer research and Stereochemistry are her primary areas of study. Her study on Cell biology is mostly dedicated to connecting different topics, such as Cell cycle. Her work carried out in the field of Kinase brings together such families of science as Mitochondrion, Function and Phosphorylation.
Her Cancer research research incorporates elements of Epithelial–mesenchymal transition, Cancer, Carcinogenesis, Metastasis and Prostate cancer. Her biological study spans a wide range of topics, including Cell culture, In vitro, Chemical synthesis, Cytotoxicity and Aryl. In her study, which falls under the umbrella issue of MAP2K7, Receptor tyrosine kinase is strongly linked to Cyclin-dependent kinase 9.
Kavita Shah mainly investigates Cancer research, Prostate cancer, Carcinogenesis, Phosphorylation and Kinase. The Cancer research study combines topics in areas such as Epithelial–mesenchymal transition and Kinase activity. Her study in Carcinogenesis is interdisciplinary in nature, drawing from both Androgen deprivation therapy and Androgen receptor.
Phosphorylation is a subfield of Cell biology that Kavita Shah studies. Her study in the field of Cytochrome c also crosses realms of Proinflammatory cytokine. She has researched Kinase in several fields, including Computational biology and Function.
Kavita Shah spends much of her time researching Cancer research, Prostate cancer, Kinase, Androgen deprivation therapy and Carcinogenesis. Her research in Cancer research intersects with topics in Epithelial–mesenchymal transition, Cell growth, Circulating tumor cell and Kinase activity. Her Prostate cancer study incorporates themes from Hypoxia, Gene knockdown and Pathogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Targets of the cyclin-dependent kinase Cdk1
Jeffrey A. Ubersax;Erika L. Woodbury;Erika L. Woodbury;Phuong N. Quang;Phuong N. Quang;Maria Paraz;Maria Paraz.
Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates
Kavita Shah;Yi Liu;Carl Deirmengian;Kevan M. Shokat.
Proceedings of the National Academy of Sciences of the United States of America (1997)
A Chemical-Genetic Strategy Implicates Myosin-1c in Adaptation by Hair Cells
Jeffrey R. Holt;Susan K.H. Gillespie;D.William Provance;Kavita Shah.
Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo.
Barbara Murdoch;Kristin Chadwick;Matthew Martin;Farbod Shojaei.
Proceedings of the National Academy of Sciences of the United States of America (2003)
ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation
Hasem Habelhah;Kavita Shah;Lan Huang;Antje Ostareck-Lederer.
Nature Cell Biology (2001)
Design of allele-specific inhibitors to probe protein kinase signaling
Anthony C. Bishop;Kavita Shah;Yi Liu;Laurie Witucki.
Current Biology (1998)
Engineering Src family protein kinases with unnatural nucleotide specificity
Yi Liu;Kavita Shah;Feng Yang;Laurie Witucki.
Chemistry & Biology (1998)
Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Dalip Kumar;N. Maruthi Kumar;Kuei-Hua Chang;Kavita Shah.
European Journal of Medicinal Chemistry (2010)
Unnatural ligands for engineered proteins: new tools for chemical genetics.
Anthony Bishop;Oleksandr Buzko;Stephanie Heyeck-Dumas;Ilyoung Jung.
Annual Review of Biophysics and Biomolecular Structure (2000)
Generation of Monospecific Nanomolar Tyrosine Kinase Inhibitors via a Chemical Genetic Approach
Anthony C. Bishop;Chi-yun Kung;Kavita Shah;Laurie Witucki.
Journal of the American Chemical Society (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: